 | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | China's public health governance is expected to come under acute pressure in coming weeks as the biggest wave of COVID-19 cases since the 2020 Wuhan outbreak stretches medical resources, tests the country's ability to contain infections and strains the economy. | | | | | | Bristol Myers Squibb and Nektar Therapeutics said on Monday they would discontinue two late-stage studies testing their combination therapy in melanoma patients after one of the trials failed to meet the main goals. | | | | | | (Reuters) - Figures showing a global rise in COVID-19 cases could herald a much bigger problem as some countries also report a drop in testing rates, the WHO said on Tuesday, warning nations to remain vigilant against the virus. | | | | | | Canada is expected to announce on Thursday that travelers entering the country will no longer have to take a pre-arrival COVID-19 test, CBC News reported, citing sources. | | | | | | Citigroup Inc has started covering travel expenses for employees who go out of state for abortions because of newly enacted restrictions in Texas and other places, becoming the first major U.S. bank to make that commitment. | | | | | | COVID-19 infections and deaths are declining in most of the Americas, the Pan American Health Organization (PAHO) said on Wednesday, with the exception of the Caribbean and Atlantic Ocean Islands where cases increased by 56.6% in the past week. | | | | | | Figures showing a global rise in COVID-19 cases could herald a much bigger problem as some countries also report a drop in testing rates, the WHO said on Tuesday, warning nations to remain vigilant against the virus. | | | | | | Negotiations on boosting the World Health Organization's budget to help it prepare for future pandemics made mixed progress last week, with Washington withdrawing criticism but other donors voicing opposition, sources involved in the talks told Reuters. | | | | | | China-based Sinovac Biotech Ltd's COVID-19 vaccine was 38.2% effective in preventing infections during the Omicron wave in children aged three to five years, a study in Chile showed. | | | | | |
